Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis

Altered metabolism of glucose, lipid and glutamine is a prominent hallmark of cancer cells. Currently, cell heterogeneity is believed to be the main cause of poor prognosis of glioblastoma (GBM) and is closely related to relapse caused by therapy resistance. However, the comprehensive model of genes...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Zheng, Wang, Chengcheng, Xue, Hao, Zhao, Rongrong, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523182/
https://www.ncbi.nlm.nih.gov/pubmed/33042807
http://dx.doi.org/10.3389/fonc.2020.01631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523182/
https://www.ncbi.nlm.nih.gov/pubmed/33042807
http://dx.doi.org/10.3389/fonc.2020.01631

Ejemplares similares